Pharmaceutical Preparations · P7 · CIK 1936258
Develops and commercializes obicetrapib, an oral therapy to lower LDL-C for cardiometabolic diseases
Comparable business profile · signals at a glance
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Lange Louis GDirector | Sell | 44,173 | $30.41 | $1.3M |
| Mar 11, 2026 | Lange Louis GDirector | Sell | 446 | $31.23 | $14K |
| Mar 9, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sell | 101,409 | $30.29 | $3.1M |
| Mar 6, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sell | 94,124 | $30.32 | $2.9M |
| Mar 6, 2026 | Lange Louis GDirector | Sell | 28,186 | $29.41 | $829K |
| Mar 5, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sell | 104,467 | $30.30 | $3.2M |
| Mar 2, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 443,707 | $33.25 | $14.8M |
| Feb 26, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 165,408 | $33.63 | $5.6M |
| Feb 26, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 17,924 | $34.44 | $617K |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 46,517 | $35.11 | $1.6M |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 10,436 | $35.96 | $375K |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 1,300 | $36.68 | $48K |
| Feb 24, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 61,547 | $36.13 | $2.2M |
| Feb 24, 2026 | Davidson Michael H.Chief Executive Officer | Sell | 3,161 | $36.46 | $115K |
| Feb 20, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sell | 30,789 | $35.46 | $1.1M |
| Feb 20, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sell | 14,692 | $35.00 | $514K |
| Jan 28, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sell | 32,612 | $31.80 | $1.0M |
| Jan 27, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sell | 39,816 | $32.62 | $1.3M |
| Jan 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sell | 34,091 | $32.77 | $1.1M |
| Jan 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sell | 309 | $33.45 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.